These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9340559)

  • 1. [AIDS; new developments. I. HIV tests: time for a more active policy].
    Coutinho RA
    Ned Tijdschr Geneeskd; 1997 May; 141(21):1034-6. PubMed ID: 9340559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recommendation of GESIDA (AIDS Study Group)/National Plan on AIDS with respect to the anti-retroviral treatment in adult patients infected with the human immunodeficiency virus in the year 2000 (I)].
    Miró JM; Antela A; Arrizabalaga J; Clotet B; Gatell JM; Guerra L; Iribarren JA; Laguna F; Moreno S; Parras F; Rubio R; Santamaría JM; Viciana P
    Enferm Infecc Microbiol Clin; 2000; 18(7):329-51. PubMed ID: 11109725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of AIDS and death at given HIV-RNA and CD4 cell count, in relation to specific antiretroviral drugs in the regimen.
    Olsen CH; Gatell J; Ledergerber B; Katlama C; Friis-Møller N; Weber J; Horban A; Staszewski S; Lundgren JD; Phillips AN;
    AIDS; 2005 Feb; 19(3):319-30. PubMed ID: 15718843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretroviral therapy: are we aware of adverse effects?
    Wig N
    J Assoc Physicians India; 2002 Sep; 50():1163-71. PubMed ID: 12516702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [AIDS: the impact of new molecules].
    Clumeck N
    Rev Med Brux; 1999 Sep; 20(4):A373-6. PubMed ID: 10523926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of seropositivity and problems linked to the identification of seropositive persons].
    Fara GM; Guasticchi G
    Nuovi Ann Ig Microbiol; 1988; 39(4-5):343-5. PubMed ID: 3254488
    [No Abstract]   [Full Text] [Related]  

  • 10. Causes of the decline in AIDS deaths, United States, 1995-2002: prevention, treatment or both?
    Holtgrave DR
    Int J STD AIDS; 2005 Dec; 16(12):777-81. PubMed ID: 16336756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV/AIDS in China. A new treatment campaign, but with limited weapons.
    Cohen J
    Science; 2004 Jun; 304(5676):1433. PubMed ID: 15178778
    [No Abstract]   [Full Text] [Related]  

  • 12. The impact of the transmission dynamics of the HIV/AIDS epidemic on sexual behaviour: a new hypothesis to explain recent increases in risk taking-behaviour among men who have sex with men.
    Boily MC; Godin G; Hogben M; Sherr L; Bastos FI
    Med Hypotheses; 2005; 65(2):215-26. PubMed ID: 15922091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on issues for HIV management.
    Bradford D
    Aust Fam Physician; 1997 Jul; 26(7):812-7. PubMed ID: 9232919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substantial cost savings seen in delaying the onset of AIDS.
    AIDS Policy Law; 1999 Oct; 14(20):5. PubMed ID: 11367060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of wasting and opportunistic infections in HIV-infected patients in West Africa: a realistic and necessary strategy before antiretroviral treatment].
    Ledru é ; Sanou PT; Dembele M; Dahourou H; Zoubga A; Durand G
    Sante; 1999; 9(5):293-300. PubMed ID: 10657773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination antiretroviral therapy and recent declines in AIDS incidence and mortality.
    Vittinghoff E; Scheer S; O'Malley P; Colfax G; Holmberg SD; Buchbinder SP
    J Infect Dis; 1999 Mar; 179(3):717-20. PubMed ID: 9952385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic impact of delaying or preventing AIDS in persons with HIV.
    Pinkerton SD; Holtgrave DR
    Am J Manag Care; 1999 Mar; 5(3):289-98. PubMed ID: 10351025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral drugs in the treatment of people living with human immunodeficiency virus: experience in a south Indian tertiary referral centre.
    Kumarasamy N; Solomon S; Peters E; Amalraj RE; Purnima M; Ravikumar B; Yepthomi T; Thyagarajan SP
    J Assoc Physicians India; 2000 Apr; 48(4):390-3. PubMed ID: 11273171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes of knowledge of HIV-positivity before development of AIDS among Danish patients with AIDS 1988-1997].
    Smith E; Graversen L
    Ugeskr Laeger; 1999 May; 161(22):3281-5. PubMed ID: 10485207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance of genotypic resistance mutations in chronic HIV-1 treated individuals after completion of the National Access to Antiretroviral Program in Thailand.
    Sukasem C; Churdboonchart V; Chasombat S; Kohreanudom S; Watitpun C; Pasomsub E; Piroj W; Tiensuwan M; Chantratita W
    Infection; 2007 Apr; 35(2):81-8. PubMed ID: 17401711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.